Danish company to wage war on drug giant
The lines have been drawn for a major patent fight between the Danish biotech company Forward Pharma and the US-based drug giant Biogen Idec concerning a blockbuster drug.
BY HENRIK TÜCHSEN, LEONORA BECK, STEFAN SINGH KAILAY, BENJAMIN WERNER CHRISTENSEN & MARTIN HAVTORN PETERSEN
The initial outline for a large-scale fight between the small, but hugely ambitious, Danish biotech outfit, Forward Pharma, and the US drug giant Biogen Idec has been drawn.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Biotech boss joins Forward Pharma’s board
For abonnenter
